Skip to main content
. 2021 Dec 30;14(1):87. doi: 10.3390/pharmaceutics14010087

Figure 5.

Figure 5

In vitro aerodynamic performance of the formulations: (A) the emitted fraction, (B) the fine particle fraction, (C) the mass median aerodynamic diameter.